Remove Extraction Remove Patients Remove Pharmaceutical Remove Sativa
article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.

article thumbnail

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Marijuana for Nausea: Helping Cancer Patients for Decades

Greencamp

Since then, countless patients found relief in cannabis, even though most of the times doctors would only recommend it when all other “mainstream” options were exhausted. However, some people don’t react well to antiemetics—most notably cancer patients going through aggressive chemo. Durban Poison (Sativa). GSC (Hybrid).

article thumbnail

The Top 7 Myths About Medical Cannabis Debunked

United Patients Group

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! In fact, there are some patients who prefer not to smoke because of their health conditions or other reasons. Myth: Cannabis is a cure-all.

article thumbnail

New Study From UNM Shows Full Spectrum Hemp Oil Effective in Treating Chronic Neuropathic Pain

MedicalJane

The UNM researchers set out to examine the effectiveness of consuming “legal” hemp oil extracted from the whole Cannabis plant. A chronic neuropathic pain model was used that exposed mice to post-operative neuropathic pain equivalent to several years of chronic pain in human patients. Westlund, Department of Anesthesiology.

Oil 100
article thumbnail

Global Legal Chronicle Article: Medical Cannabis regulation slowly advances in Brazil

Cannabis Law Report

extracts, the number of countries with specific regulations also increases. In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment.

Sativa 59
article thumbnail

Heritage Cannabis Enters Exclusive Partnership to Commercialize Avicanna’s Evidence-Based Topical Products through Heritage’s Medical Opticann Brands

Cannabis Law Report

The Licensing Agreement is for the commercialization of a number of Avicanna’s advanced CBD-based topical products under Heritage’s medical cannabis brands (the “Branded Products”) targeting patients registered to purchase medical cannabis in Canada. They are a great strategic fit.

Topical 98